Last reviewed · How we verify
Multiple Product PrEP Program
A program providing multiple antiretroviral formulations for pre-exposure prophylaxis (PrEP) to prevent HIV acquisition in at-risk individuals.
A program providing multiple antiretroviral formulations for pre-exposure prophylaxis (PrEP) to prevent HIV acquisition in at-risk individuals. Used for HIV pre-exposure prophylaxis (PrEP) in at-risk individuals without HIV infection.
At a glance
| Generic name | Multiple Product PrEP Program |
|---|---|
| Sponsor | University of Alabama at Birmingham |
| Drug class | Antiretroviral combination therapy (nucleoside/nucleotide reverse transcriptase inhibitors) |
| Target | HIV reverse transcriptase, HIV integrase |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Virology |
| Phase | FDA-approved |
Mechanism of action
The Multiple Product PrEP Program offers various FDA-approved PrEP medications (primarily tenofovir/emtricitabine-based regimens) through the University of Alabama at Birmingham to increase access and adherence to HIV prevention. These antiretrovirals work by inhibiting reverse transcriptase and integrase enzymes critical to HIV replication, providing protection when taken consistently before potential exposure.
Approved indications
- HIV pre-exposure prophylaxis (PrEP) in at-risk individuals without HIV infection
Common side effects
- Nausea
- Headache
- Abdominal pain
- Renal function changes
- Bone density loss
Key clinical trials
- Integrated HIV Prevention and HCV Care for PWID (NA)
- Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Multiple Product PrEP Program CI brief — competitive landscape report
- Multiple Product PrEP Program updates RSS · CI watch RSS
- University of Alabama at Birmingham portfolio CI